Urinary tract infections (UTIs) are among the most common infectious diseases of humans, with Escherichia coli being responsible for >80% of all cases. Asymptomatic bacteriuria (ABU) occurs when bacteria colonize the urinary tract without causing clinical symptoms and can affect both catheterized patients (catheterassociated ABU [CA-ABU]) and noncatheterized patients. Here, we compared the virulence properties of a collection of ABU and CA-ABU nosocomial E. coli isolates in terms of antibiotic resistance, phylogenetic grouping, specific UTI-associated virulence genes, hemagglutination characteristics, and biofilm formation. CA-ABU isolates were similar to ABU isolates with regard to the majority of these characteristics; exceptions were that CA-ABU isolates had a higher prevalence of the polysaccharide capsule marker genes kpsMT II and kpsMT K1, while more ABU strains were capable of mannose-resistant hemagglutination. To examine biofilm growth in detail, we performed a global gene expression analysis with two CA-ABU strains that formed a strong biofilm and that possessed a limited adhesin repertoire. The gene expression profile of the CA-ABU strains during biofilm growth showed considerable overlap with that previously described for the prototype ABU E. coli strain, 83972. This is the first global gene expression analysis of E. coli CA-ABU strains. Overall, our data suggest that nosocomial ABU and CA-ABU E. coli isolates possess similar virulence profiles.Urinary tract infections (UTIs) are among the most common infectious diseases acquired in nosocomial settings. UTIs may be symptomatic (e.g., cystitis and pyelonephritis) or asymptomatic. Asymptomatic bacteriuria (ABU) is an asymptomatic carrier state that resembles commensalism. ABU patients often carry Ͼ105 CFU/ml of urine of a single bacterial strain without symptoms; in nosocomial settings, ABU frequently occurs in both catheterized and noncatheterized patients. In catheterized patients, the risk of bacteriuria is estimated to be 5 to 10% per day (46), and most patients with an indwelling urinary catheter for 30 days or longer develop bacteriuria (35). ABU in catheterized and noncatheterized patients may also lead to symptomatic UTIs, with patients experiencing fever, suprapubic tenderness, and, in some cases, bacteremia, acute pyelonephritis, and death (16,45).ABU is caused by a range of Gram-negative and Grampositive organisms, including Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Providencia stuartii, Staphylococcus epidermidis, and Enterococcus faecalis (16,46). In many cases, the bacteria that cause these infections are resistant to multiple antibiotics, and thus, they pose a serious threat to the safety and proper functioning of health care facilities. E. coli is one of the most common causes of nosocomial UTIs (including ABU) (17, 36). Many ABU E. coli strains are phylogenetically related to virulent uropathogenic E. coli (UPEC) strains, with the differences in virulence properties being multifactorial and associated with various co...